Literature DB >> 11841695

Generation of antibodies to the signal peptide of the MPT83 lipoprotein of Mycobacterium tuberculosis.

M Harboe1, A O Whelan, G Ulvund, J McNair, J M Pollock, R G Hewinson, H G Wiker.   

Abstract

The mpt83 gene (Rv2873) encodes the exported MPT83 lipoprotein of Mycobacterium tuberculosis. The corresponding identical mpb83 gene of Mycobacterium bovis is expressed to varying extents in different substrains of M. bovis Bacille Calmette Guerin (BCG), BCG Tokyo and BCG Moreau being high producers and BCG Danish 1331, a low producer of the MPB83 protein. Immunization with the 13-mer N-terminal part of the signal peptide of MPT83, MINVQAKPAAAASC, coupled to keyhole limpet haemocyanin (KLH) through the added C-terminal cysteine resulted in rapid antibody formation monitored by enzyme-linked immunosorbent assay (ELISA) with free immunizing peptide on the solid phase. In ELISA, with four 20-mer overlapping peptides covering the N-terminal part of the MPT83 sequence, three polyclonal rabbit antisera reacted only with the N-terminal peptide. Antigenic signal peptide could not be detected in sonicates of BCG Tokyo and BCG Moreau. After SDS-PAGE and blotting, the antibodies reacted with sonicates of recombinant Escherichia coli containing the entire mpt83 gene including the signal sequence, but not with the 22 kDa form of native MPB83 purified from BCG culture filtrate. In partition chromatography the recMPT83 partitioned in the water phase while 26 kDa MPB83 in BCG culture filtrate partitioned in the lipid phase confirming that lipidation at the N-terminal cysteine residue occurs after the splitting of the polypeptide chain by signal peptidase II.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841695     DOI: 10.1046/j.1365-3083.2002.01030.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis.

Authors:  Riva Kovjazin; Anna Dubnik; Galit Horn; Nechama I Smorodinsky; Izhar Hardan; Michael Yechiel Shapira; Lior Carmon
Journal:  Exp Ther Med       Date:  2012-04-03       Impact factor: 2.447

2.  Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects.

Authors:  Abu S Mustafa
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

3.  Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain.

Authors:  Meru Sheel; Manisha Pandey; Michael F Good; Michael R Batzloff
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

4.  Analysis of the shotgun expression library of the Mycobacterium tuberculosis genome for immunodominant polypeptides: potential use in serodiagnosis.

Authors:  Prakash S Bisen; Sanjay K Garg; Ram P Tiwari; P Ravindra Nath Tagore; Ramesh Chandra; Rucha Karnik; Nimesh Thaker; Nirav Desai; P K Ghosh; Maurizio Fraziano; Vittorio Colizzi
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

5.  PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.

Authors:  Anneliese S Ashhurst; Thaigarajan Parumasivam; John Gar Yan Chan; Leon C W Lin; Manuela Flórido; Nicholas P West; Hak-Kim Chan; Warwick J Britton
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.